文献速递免疫规划妇幼与学校卫生慢病防控与筛查

澳大利亚原住民女性接种疫苗后人乳头瘤病毒感染率下降:VIP-I研究

Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
PubMed 文献 · Vaccine · 2018-06-05

该研究采用重复横断面设计,比较2007年疫苗接种前与2014-15年澳大利亚原住民女性中人乳头瘤病毒(HPV)感染率。结果显示,任何HPV型别感染比例从58%降至36%,疫苗型别感染比例从24%降至1.4%,下降94%。澳大利亚国家HPV疫苗接种项目似乎成功保护了高风险原住民女性。

要点

  • 澳大利亚原住民女性宫颈癌风险高,主要因筛查不足。
  • 疫苗接种后任何HPV型别感染从58%降至36%。
  • 疫苗型别HPV感染从24%降至1.4%,下降94%。

核心结论

  • 澳大利亚国家HPV疫苗接种项目似乎成功保护了极高比例的原住民女性免受疫苗靶向HPV型别感染,该人群既往宫颈癌风险升高。

研究设计与样本

  • 重复横断面设计,基线为2007年疫苗接种项目开始前在原住民女性中开展的HPV患病率调查,2014-15年重返四个地点的诊所招募18-26岁筛查女性。
  • 共招募142名女性,与2007年疫苗前调查在同一地点招募的155名女性进行比较。

主要发现

  • 两组年龄相同,近期组激素避孕使用者比例更高,吸烟者比例更低。
  • 任何HPV型别感染比例从58%降至36%,下降完全归因于疫苗型别感染减少。
  • 疫苗型别HPV感染从24%降至1.4%,下降94%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cervical cancer occurrence and mortality are strongly correlated with socioeconomic disadvantage, largely due to unequal access to screening and treatment. Universal human papillomavirus (HPV) vaccination provides the opportunity to greatly reduce this global health disparity. Australian Indigenous women have substantially higher rates of cervical cancer than non-Indigenous women, primarily due to under-screening. We investigated HPV infection rates in Indigenous women 7 years after implementation of the national HPV vaccination program. METHODS: We used a repeat cross-sectional design, with the baseline being provided by an HPV prevalence survey among Indigenous women attending clinics for cervical cytology screening, prior to the start of the vaccination program in 2007. We returned to clinics in four locations during 2014-15, and invited women aged 18-26 years attending for screening to provide a cervical specimen for HPV testing, as well as to complete a short questionnaire and consent to allow access of their records in the National HPV Vaccination Program Register. We used well-established laboratory methods to test specimens for specific HPV genotypes. RESULTS: A total of 142 women were recruited at participating sites and compared to 155 who had been recruited at the same locations in the 2007 pre-vaccine survey. The two groups were identical in regard to age, with the more recent group having a higher proportion of hormonal contraception users, and a lower proportion of smokers. The proportion found to have any HPV type fell from 58 to 36% with the decline being entirely due to reductions in vaccine types, which fell by 94% from 24 to 1.4%. CONCLUSION: Australia's national HPV vaccination program appears to be successfully protecting a very high proportion of Indigenous women against vaccine targeted HPV types, who have in the past been at elevated risk of cervical cancer.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McGregor S, Saulo D, Brotherton JML, et al. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. Vaccine. 2018. PMID: 29880245. doi:10.1016/j.vaccine.2018.05.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。